This insider cluster is too small in dollar terms to be a meaningful signal. Monitor for any larger insider sales or purchases in the coming weeks, but no immediate action is warranted based on this filing alone.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Sep 8 $42.45entry
- T+1 · 2mo ago +3.32%α +3.79% · $43.86
- T+5 · 2mo ago −5.44%α −4.32% · $40.14
- T+20 · 6w ago +5.18%α +3.47% · $44.65
- T+49 · todayOpen
- T+60 · in 15d Pending
Price Chart
How similar events traded
Executive Summary
Four Veracyte insiders, including the CFO and Chief Scientific & Medical Officer, sold a total of ~$396K in open-market stock over a 3-day window. While the cluster includes C-suite participants, the total value represents only ~0.01% of the company's $3.6B market cap, making it a trivial, routine event. The sales are likely liquidity-driven following a vesting event on 9/2, where multiple executives also surrendered shares for tax withholding, and do not signal a bearish view on the business.
Key Financial Metrics
Key Facts
- Four insiders sold ~$396K in open-market shares over 3 days (9/1-9/4/2026).
- Total open-market sales represent ~0.01% of VCYT's $3.6B market cap, a trivial amount.
- Sales follow a 9/2 vesting event where 6 insiders surrendered shares for tax withholding, suggesting liquidity-driven selling.
- Participants include CFO, Chief Scientific & Medical Officer, EVP/General Counsel, and a Director.
- No insider open-market purchases were reported in the cluster.
Financial Impact
Open-market sales of ~$396K, or ~0.01% of market cap, immaterial.
Risk Factors
- Insider sales could accelerate if the stock continues to appreciate, but current levels are routine.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-VCYT-1788566462155 |
Track record
22 reports on VCYT
4 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +20.37% at T+20 after the Jun 11, 2026 report. 6 of 6 went positive at some point.
Filters
- Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $24.63 Now $24.33 −1.22% settles Dec 11
- Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $24.00 Now $24.33 +1.37% settles Dec 4
- Nov 4, 202612d ago 8-K Neutral 5/10 Entry $24.00 Now $24.33 +1.37% settles Dec 4
- Oct 30, 202617d ago Institutional Cluster Neutral 3/10 Entry $50.01 Now $24.33 −51.35% settles Nov 30
- Oct 28, 202619d ago Insider Cluster Neutral 2/10 Entry $52.17 Now $24.33 −53.36% settles Nov 27
- Oct 28, 202619d ago Insider Cluster Neutral 3/10 Entry $52.17 Now $24.33 −53.36% settles Nov 27
- Oct 27, 202620d ago 144 Neutral 2/10 Entry $50.31 Now $24.33 −51.64% settles Nov 25
- Oct 27, 202620d ago 144 Neutral 2/10 Entry $50.31 Now $24.33 −51.64% settles Nov 25
- Sep 22, 20267w ago Insider Cluster Neutral 2/10 Entry $43.82 to $46.22 Now $24.33 −44.48% ▲ +5.48% +4.79% vs SPY
- Sep 14, 20269w ago Press Release Bullish 6/10 Entry $40.14 to $43.11 Now $24.33 −39.39% ▲ +7.40% +4.68% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers